Streetbeat News

Regulatory

BROG

Brooge Energy has received a non-compliance letter from Nasdaq, indicating that the company is not meeting certain listing requirements.

Portfolio Pulse from Benzinga Newsdesk

June 05, 2024 | 8:40 pm

NVAX

Novavax announced that an FDA panel has backed an update for the monovalent JN.1-lineage COVID vaccine. Novavax plans to deliver its protein-based JN.1 COVID vaccine and expects to be ready for delivery in September.

Portfolio Pulse from Benzinga Newsdesk

June 05, 2024 | 8:36 pm

MDAI

Spectral AI received a letter from Nasdaq on June 3, indicating that the company is not currently in compliance with Nasdaq's listing requirements, according to an SEC filing.

Portfolio Pulse from Benzinga Newsdesk

June 05, 2024 | 8:35 pm

BRKH

BurTech Acquisition Corp. (BRKH) has received a notice from Nasdaq regarding non-compliance with listing requirements.

Portfolio Pulse from Benzinga Newsdesk

June 05, 2024 | 8:32 pm

PEGR

Project Energy Reimagined Acquisition Corp. (PEGR) has received a late filing notice from Nasdaq.

Portfolio Pulse from Benzinga Newsdesk

June 05, 2024 | 8:28 pm

PWUP

PowerUp Acquisition Corp. (NASDAQ:PWUP) received a deficiency notice from Nasdaq for not complying with the timely filing requirement under Nasdaq Listing Rule 5250(c)(1).

Portfolio Pulse from Benzinga Newsdesk

June 05, 2024 | 8:25 pm

BNTX

CVAC

MRNA

PFE

ZTS

The World Health Organization (WHO) has confirmed the first-ever human death from the bird flu strain H5N2 in Mexico. The individual, who was infected on April 17, succumbed to complications from the condition.

Portfolio Pulse from Benzinga Newsdesk

June 05, 2024 | 8:22 pm

ICCC

ImmuCell Corporation (Nasdaq: ICCC) provided a regulatory update on the status of its product development initiative for Re-Tain®, a product aimed at improving the health and productivity of dairy and beef cattle.

Portfolio Pulse from Benzinga Newsdesk

June 05, 2024 | 8:21 pm

HALO

Halozyme Therapeutics, Inc. (NASDAQ:HALO) has been granted a new European patent for its ENHANZE drug delivery platform, which will be validated in 37 European countries and expires on March 6, 2029. A conference call is scheduled for June 6, 2024.

Portfolio Pulse from Benzinga Newsdesk

June 05, 2024 | 8:08 pm

MSGM

Motorsport Games has announced that it has regained compliance with the continued listing requirements of the Nasdaq Stock Market.

Portfolio Pulse from Benzinga Newsdesk

June 05, 2024 | 8:02 pm